Clinical Trial Update: Study of Alfimeprase to Rapidly Dissolve Blood Clots in the Leg and Help Prevent the Need for Surgery on Leg Arteries [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial of Alfimeprase for rapidly dissolving leg blood clots (to reduce the need for leg-artery surgery) has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Artery Disease

Drugs mentioned

• Alfimeprase (alfimeprase)

Snippet

Sponsor: ARCA Biopharma, Inc. | Conditions: Arterial Occlusive Diseases | Phase 3 | Status: COMPLETED